Form 4: Intuitive Surgical Officer Sells Shares Under 10b5-1 Plan

Myriam Curet, EVP & Chief Medical Officer of Intuitive Surgical, executed a pre-planned sale of 105 common shares after exercising stock options.

Summary

• Myriam Curet, EVP & Chief Medical Officer of Intuitive Surgical Inc. (ISRG), reported a change in beneficial ownership.
• On November 10, 2025, Curet exercised 105 non-qualified stock options at a price of $229.39 per share.
• Concurrently, Curet sold 105 shares of common stock at a price of $560 per share.
• These transactions were conducted under a Rule 10b5-1 trading plan, which is set to expire on July 29, 2026.
• Following these transactions, Curet directly owns 0 shares of common stock and indirectly owns 353 shares through a trust.
• Curet retains 1,571 non-qualified stock options.

Sentiment

Score: 5

Explanation: The filing reports a routine, pre-planned insider transaction (exercise of options and sale of shares) under a 10b5-1 plan. Such transactions are generally neutral in sentiment as they are part of executive compensation and personal financial management, rather than a reflection of new company performance or strategic shifts.

Positives

• The exercise of options indicates the reporting person realized value from their compensation.
• The sale was executed at a significantly higher price ($560) than the exercise price ($229.39), indicating a profitable transaction for the insider.

Negatives

• The sale of shares by a key executive could be perceived negatively by some investors, though it was pre-planned.
• The direct beneficial ownership of common stock is now 0 shares for the reporting person.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This is a routine insider transaction report and does not provide specific insights into broader industry trends or competitive landscape. It reflects an individual executive's compensation management.

Comparison to Industry Standards

• This filing reports a standard insider transaction (exercise and sale) under a Rule 10b5-1 plan, which is a common practice among executives in publicly traded companies across various industries to manage personal finances and diversify holdings while avoiding accusations of trading on material non-public information. No specific comparable companies or projects are relevant for this type of filing.

Stakeholder Impact

• Shareholders: Minimal impact. This is a routine, pre-planned transaction by an executive, not indicative of a change in company fundamentals or a lack of confidence.
• Employees: No direct impact.
• Customers: No direct impact.
• Suppliers: No direct impact.
• Creditors: No direct impact.

Next Steps

• Continued vesting of the remaining 1,571 non-qualified stock options according to the schedule (1/48th monthly for 42 months after the initial 12.5% vesting).
• The Rule 10b5-1 trading plan will remain active until its expiration on July 29, 2026.

Key Dates

Recommendation

This Form 4 filing details a routine, pre-planned insider transaction where an executive exercised stock options and immediately sold a portion of the acquired shares under a Rule 10b5-1 plan. Such transactions are common for executive compensation and personal financial management and typically do not reflect new material information about the company's operational performance or strategic direction. Therefore, this specific filing alone does not warrant a change in investment recommendation; a 'hold' stance is maintained, pending further fundamental analysis of the company's broader financial reports and market position.

Keywords

Intuitive Surgical, ISRG, Form 4, Insider Trading, Stock Option Exercise, Share Sale, 10b5-1 Plan, Myriam Curet, Executive Compensation